Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Ideal candidates for this treatment include individuals managing conditions such as Type 1 diabetes, Type 2 diabetes, prediabetes, insulin resistance, or diabetic neuropathy
However, the above-linked study doesn't appear to be published in any peer-reviewed journals
Early studies showed that sitagliptin induced decreased expression of pro-inflammatory proteins and decreased monocyte migration in apolipoprotein E-deficient mice may be attributed to GLP-1, which reduces monocyte migration and exerts anti-inflammatory effects by decreasing NFB [18, 19]
Supports Circulation in the Brain *
R., De las Penas, C
Overall, the available research suggests that treatment with intravenous or oral lipoic acid may help reduce symptoms of diabetic peripheral neuropathy
